(5E)-5-(2,6-dichlorobenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

2,6-Dichloro-3-hydroxyisonicotinaldehyde, 95.0%, 250mg

benzyl[(2R)-1-methoxy-1-oxopropan-2-yl]azanium chloride, 98.0%, 5g

1-[4-(cyclopentylamino)-2-(methylsulfanyl)pyrimidin-5-yl]ethan-1-one, 98%, 500mg

(2R)-2-[3-(Trifluoromethyl)phenyl]pyrrolidine, 97%, 250mg

5-Ethyl-4-methyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 2.5g

4,4'-[[1,1'-Biphenyl]-4,4'-diylbis(oxy)]bis[3-(trifluoromethyl)aniline]>95.0%(HPLC)(T)1g

1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)ethanone, 95.0%, 250mg

7-METHYLXANTHINE, 98%, 100mg

1,4-Dibromo-2,5-dimethoxybenzene, 98.0%, 25g

4-Bromo-3-fluorobenzenesulfonyl Chloride>98.0%(GC)(T)5g

Solución estándar de praseodimio ICP, ROTI®Star, 10000 mg/l Pr, densidad (D) ~1 g/cm³

1,3-Dihydro-indole-2-thione, 95.0%, 500mg